Unusual 11 Mid-Day Movers 02/01: (OTT) (BBW) (ALIM) Higher; (ECTE) (BCOV) (LTM) Lower
Tweet
Share
E-mail
Get Alerts OTT Hot Sheet
Join SI Premium – FREE
Otelco Inc. (Nasdaq: OTT) 35.2% HIGHER; announced a restructuring transaction, which it says will strengthen the Company by deleveraging its balance sheet and reducing its overall indebtedness by approximately $135 million. Click here for more color.
Echo Therapeutics, Inc. (Nasdaq: ECTE) 31.0% LOWER; announced the pricing of a previously announced underwritten public offering of 13,333,333 shares of its common stock, offered at a price to the public of $0.75 per share.
Build-A-Bear Workshop, Inc. (NYSE: BBW) 25.6% HIGHER; CEO Maxine Clark will retire and the company announced preliminary fourth-quarter results. For more color, click here.
Alimera Sciences, Inc. (Nasdaq: ALIM) 24.5% HIGHER; moving strong above the $2 level on volume today. A publication in JAMA Ophthalmology Journal questioned the effectiveness of Roche's (OTCBB: RHHBY) Lucentis and saline on the rate of vitrectomy in patients with vitreous hemorrhage tied to diabetic retinopathy.
Brightcove (Nasdaq: BCOV) 23.6% LOWER; reported Q4 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $24.3 million versus the consensus estimate of $23.15 million. Sees Q1 2013 EPS of ($0.08)-($0.10), versus the consensus of ($0.06). Brightcove sees Q1 2013 revenue of $23.5-$24 million, versus the consensus of $24.15 million. Brightcove sees FY2013 EPS of ($0.18)-($0.25), versus the consensus of ($0.15). Brightcove sees FY2013 revenue of $102-$105 million, versus the consensus of $106.2 million.
Audience (Nasdaq: ADNC) 21.1% HIGHER; reported Q4 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $38.7 million versus the consensus estimate of $37.04 million. Sees Q1 2013 EPS of $0.15-0.19, versus the consensus of $0.01. Audience sees Q1 2013 revenue of $43-46 million, versus the consensus of $31.82 million.
Life Time Fitness, Inc. (NYSE: LTM) 21.1% LOWER; reported light Q4 expectations and cut its 2012 outlook. For more color on the move, click here.
Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) 17.5% LOWER; pulling back after several sessions of massive gains.
pSivida Corp. (Nasdaq: PSDV) 15.3% HIGHER; also higher on Roche news. See Alimera above.
Abaxis, Inc. (Nasdaq: ABAX) 14.9% HIGHER; reported Q3 EPS of $0.22, $0.02 better than the analyst estimate of $0.20. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $45.75 million.
Celsion Corp. (Nasdaq: CLSN) 14.6% LOWER; entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., as sales agent, pursuant to which Celsion may offer and sell, from time to time, through Cantor shares of common stock, par value $0.01 per share, of Celsion having an aggregate offering price of up to $25.0 million.
PMC-Sierra, Inc. (Nasdaq: PMCS) 14.1% HIGHER; reported Q4 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $129.4 million versus the consensus estimate of $126.5 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Echo Therapeutics, Inc. (Nasdaq: ECTE) 31.0% LOWER; announced the pricing of a previously announced underwritten public offering of 13,333,333 shares of its common stock, offered at a price to the public of $0.75 per share.
Build-A-Bear Workshop, Inc. (NYSE: BBW) 25.6% HIGHER; CEO Maxine Clark will retire and the company announced preliminary fourth-quarter results. For more color, click here.
Alimera Sciences, Inc. (Nasdaq: ALIM) 24.5% HIGHER; moving strong above the $2 level on volume today. A publication in JAMA Ophthalmology Journal questioned the effectiveness of Roche's (OTCBB: RHHBY) Lucentis and saline on the rate of vitrectomy in patients with vitreous hemorrhage tied to diabetic retinopathy.
Brightcove (Nasdaq: BCOV) 23.6% LOWER; reported Q4 EPS of ($0.05), $0.02 better than the analyst estimate of ($0.07). Revenue for the quarter came in at $24.3 million versus the consensus estimate of $23.15 million. Sees Q1 2013 EPS of ($0.08)-($0.10), versus the consensus of ($0.06). Brightcove sees Q1 2013 revenue of $23.5-$24 million, versus the consensus of $24.15 million. Brightcove sees FY2013 EPS of ($0.18)-($0.25), versus the consensus of ($0.15). Brightcove sees FY2013 revenue of $102-$105 million, versus the consensus of $106.2 million.
Audience (Nasdaq: ADNC) 21.1% HIGHER; reported Q4 EPS of $0.14, $0.04 better than the analyst estimate of $0.10. Revenue for the quarter came in at $38.7 million versus the consensus estimate of $37.04 million. Sees Q1 2013 EPS of $0.15-0.19, versus the consensus of $0.01. Audience sees Q1 2013 revenue of $43-46 million, versus the consensus of $31.82 million.
Life Time Fitness, Inc. (NYSE: LTM) 21.1% LOWER; reported light Q4 expectations and cut its 2012 outlook. For more color on the move, click here.
Keryx Biopharmaceuticals Inc. (Nasdaq: KERX) 17.5% LOWER; pulling back after several sessions of massive gains.
pSivida Corp. (Nasdaq: PSDV) 15.3% HIGHER; also higher on Roche news. See Alimera above.
Abaxis, Inc. (Nasdaq: ABAX) 14.9% HIGHER; reported Q3 EPS of $0.22, $0.02 better than the analyst estimate of $0.20. Revenue for the quarter came in at $49.8 million versus the consensus estimate of $45.75 million.
Celsion Corp. (Nasdaq: CLSN) 14.6% LOWER; entered into a Controlled Equity Offering Sales Agreement with Cantor Fitzgerald & Co., as sales agent, pursuant to which Celsion may offer and sell, from time to time, through Cantor shares of common stock, par value $0.01 per share, of Celsion having an aggregate offering price of up to $25.0 million.
PMC-Sierra, Inc. (Nasdaq: PMCS) 14.1% HIGHER; reported Q4 EPS of $0.12, $0.02 better than the analyst estimate of $0.10. Revenue for the quarter came in at $129.4 million versus the consensus estimate of $126.5 million.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Cantor Fitzgerald Starts Nuvation Bio Inc (NUVB) at Overweight
- SentinelOne Inc (S) PT Raised to $26 at Cantor Fitzgerald Following Strong Q2 Checks
- 'We expect salesforce.com (CRM) to capture a meaningful share of next-gen agentic workflows': Cantor
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Cantor Fitzgerald, Unusual 11 Mid-Day MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
